Screener
Axogen AXGN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Axogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000805928-26-000094
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 48,606 | 92,840 |
| Commitments and contingencies - see Note 14 | ||
| Shareholders’ equity | ||
| Common stock, $0.01 par value per share; 100,000,000 shares authorized; 53,656,293 and 47,199,797 shares issued and outstanding, respectively | 537 | 472 |
| Additional paid-in capital | 583,783 | 435,338 |
| Accumulated deficit | (328,063) | (306,963) |
| Total shareholders’ equity | 256,257 | 128,847 |
| Total liabilities and shareholders’ equity | $304,863 | $221,687 |
ITEM 1 — FINANCIAL STATEMENTS
FAQ
- What is Axogen's common stock?
- Axogen (AXGN) reported common stock of 100M in Q2 2026.
- How has Axogen's common stock changed year-over-year?
- Axogen's common stock decreased by 0.0% year-over-year, from 100M to 100M.
- What is the long-term trend for Axogen's common stock?
- Over 5 years (2020 to 2025), Axogen's common stock has grown at a 3.1% compound annual growth rate (CAGR), from 406K to 472K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Axogen's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude